Basilea Pharmaceutica Ltd has partnered with INCATE in Europe to support early-stage anti-infectives, including antifungals. Basilea’s expertise will help INCATE identify and advance promising innovations, bridging the gap between academic research and medical needs. The partnership aims to transform preclinical concepts into life-saving medicines through industry collaborations.

Read more at Nasdaq: Basilea Pharmaceutica Partners With INCATE To Advance Antibacterial And Antifungal Innovation